Olfa Gam, CEO of Cytopharma, Recognized as One of the "Top Healthcare Leaders 2025" by Forbes Middle East
Olfa Gam, CEO of Cytopharma, has been recognized this year by Forbes Middle East as one of the "Top Healthcare Leaders 2025", highlighting her key role in the development of the specialized pharmaceutical industry in oncology. Since 2019, Gam has led Cytopharma, a Tunisian company specializing in sterile oncological injectables, and currently oversees a team of 100 employees. Under her leadership, the company recorded a 42% growth in revenue in 2024 compared to 2023 and renewed its EU GMP certification, ensuring compliance with the strictest European standards. Olfa Gam has also initiated several strategic projects, including the creation of a joint venture for an oncology plant in Saudi Arabia and the registration of the first oncological biosimilar in Tunisia and the Commonwealth of Independent States (CIS) region. She also chairs the Tunisia Health Alliance and serves as an independent administrator on the board of Julphar, consolidating her influence in the pharmaceutical sector at the regional and international levels. Forbes Middle East highlights her ability to combine economic growth, scientific innovation, and international expansion, making Olfa Gam an indispensable figure in healthcare and pharmacy in Africa and the Middle East.
